Abstract | PURPOSE: MATERIALS AND METHODS: Twenty-one patients underwent TIPS creation for HHyd. A prospective TIPS database and medical records were reviewed. Clinical and radiographic outcomes were recorded as complete (symptom/effusion resolution), partial (improved symptoms/effusion), or none. Data patterns were examined with chi(2) tests and Kaplan-Meier analysis. RESULTS: Patients included 12 women and nine men, with a mean age of 56 years, all with Child class B (n = 7) or C (n = 14) disease. The technical success rate was 100%. Mean follow-up was 223 days. Twenty-nine percent (six of 21) died within 30 days of TIPS creation, 10% (two of 21) underwent transplantation within 30 days, and 62% (13 of 21) survived beyond 30 days. Data were incomplete in two patients. Clinical response was classified as complete in 63% (12 of 19), partial in 11% (two of 19), and none in 26% (five of 19). Radiographic response was classified as complete in 30% (six of 20), partial in 50% (10 of 20), and none in 20% (four of 20). Nonresponders had multisystem organ failure, and all but one died within 30 days. However, of the 13 patients surviving longer than 30 days, 10 (77%) had a complete clinical response. CONCLUSION:
TIPS is a relatively safe and effective method of controlling HHyd. The majority of patients experienced improvement or resolution of clinical symptoms with a variable reduction in the quantity of pleural fluid. There was a tendency among nonresponders to die within 30 days.
|
Authors | E Brooke Spencer, Daniel T Cohen, Michael D Darcy |
Journal | Journal of vascular and interventional radiology : JVIR
(J Vasc Interv Radiol)
Vol. 13
Issue 4
Pg. 385-90
(Apr 2002)
ISSN: 1051-0443 [Print] United States |
PMID | 11932369
(Publication Type: Comparative Study, Evaluation Study, Journal Article)
|
Topics |
- Adult
- Aged
- Female
- Humans
- Hydrothorax
(etiology, mortality, therapy)
- Hypertension, Portal
(complications)
- Liver Diseases
(complications)
- Liver Transplantation
- Male
- Middle Aged
- Portasystemic Shunt, Transjugular Intrahepatic
(adverse effects, mortality)
- Severity of Illness Index
- Survival Analysis
- Treatment Outcome
|